Custom Search Insider Trading Activity Insider Trading Activity

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Custom Search Insider Trading Activity

Updated Jan 2, 2024

Ticker
Company Name
Qty.
Price
Size ($)
Filing Date
Type
Δ Own
Own
Insider Names
Title
Trade Dates
Is Scheduled
Immuneering Corp
0
—
—
—
0
Jan 1
Pepgen Inc.
0
—
—
—
0
Jun 22
Immuneering Corp
0
—
—
—
0
Jun 14
Pepgen Inc.
4.17K
$12.00
$49,992.00
∞
4.17K
May 6
Imago Biosciences, Inc.
0
—
—
—
0
Jan 11
Immuneering Corp
0
—
—
—
0
Jun 21
Imago Biosciences, Inc.
0
—
—
—
0
Jun 1
Immuneering Corp
7K
$5.00
$35,000.00
+100.00%
14K
May 16
Pepgen Inc.
0
—
—
—
0
May 6
Pepgen Inc.
0
—
—
—
0
Imago Biosciences, Inc.
0
—
—
—
0
Nov 17
Imago Biosciences, Inc.
0
—
—
—
0
Alnylam Pharmaceuticals, Inc.
0
$138.95
-$1,000,000.00
—
5.13K
+1
Aug 5
Scheduled
Immuneering Corp
7K
$15.00
$105,000.00
∞
7K
Aug 3
Immuneering Corp
0
—
—
—
0
Alnylam Pharmaceuticals, Inc.
0
$133.43
-$620,328.00
—
5.13K
+1
Jul 12
Scheduled
Alnylam Pharmaceuticals, Inc.
-1.73K
$154.00
-$267,036.00
-25.25%
5.13K
+1
Jun 9
Scheduled
Alnylam Pharmaceuticals, Inc.
2.43K
$131.85
-$275,425.87
+54.74%
6.87K
+1
Apr 19 - Apr 20
Alnylam Pharmaceuticals, Inc.
0
—
—
—
0
+1
Feb 24
Alnylam Pharmaceuticals, Inc.
2.2K
$155.87
-$305,967.24
+98.61%
4.44K
+1
Feb 11 - Feb 12
Alnylam Pharmaceuticals, Inc.
0
$126.18
-$789,408.20
—
2.23K
+1
Jan 13
Scheduled
Alnylam Pharmaceuticals, Inc.
-758.00
$116.37
-$1,422,201.98
-25.33%
2.23K
+1
Jan 11 - Jan 12
Scheduled
Alnylam Pharmaceuticals, Inc.
-11.50K
$123.92
-$4,475,724.81
-79.35%
2.99K
+1
Jul 13
Scheduled
Alnylam Pharmaceuticals, Inc.
0
$108.20
-$616,000.00
—
14.49K
+1
Apr 20
Scheduled
Alnylam Pharmaceuticals, Inc.
2.23K
$104.78
-$202,547.75
+18.22%
14.49K
+1
Apr 7
Alnylam Pharmaceuticals, Inc.
0
—
—
—
0
+1
Feb 26
Alnylam Pharmaceuticals, Inc.
0
$103.20
-$516,000.00
—
12.26K
+1
Feb 10
Scheduled
Alnylam Pharmaceuticals, Inc.
3.66K
$77.40
$283,516.20
+42.62%
12.26K
+1
Jan 27
Scheduled
Alnylam Pharmaceuticals, Inc.
0
$98.20
-$263,619.20
—
8.6K
+1
Jan 29
Scheduled
Alnylam Pharmaceuticals, Inc.
-6.66K
$79.96
-$3,378,699.45
-43.67%
8.6K
+1
Jan 27
Scheduled
Alnylam Pharmaceuticals, Inc.
0
—
—
—
0
+1
Dec 23
Alnylam Pharmaceuticals, Inc.
10
—
—
+2.36%
434
+1
Oct 10 - Nov 22
Alnylam Pharmaceuticals, Inc.
49
—
—
+13.07%
424
+1
Jul 11 - Aug 6
Alnylam Pharmaceuticals, Inc.
55
—
—
+17.19%
375
+1
Oct 18 - Jun 5
Alnylam Pharmaceuticals, Inc.
0
—
—
—
0
+1
Feb 28
Alnylam Pharmaceuticals, Inc.
0
—
—
—
0
+1
Sep 27
Alnylam Pharmaceuticals, Inc.
0
—
—
—
0
+1
Aug 21
Alnylam Pharmaceuticals, Inc.
790
$90.95
-$55,024.75
+5.34%
15.58K
+1
Jul 10 - Aug 13
Alnylam Pharmaceuticals, Inc.
31
$73.63
-$98,187.66
+0.21%
14.79K
+1
Apr 16 - Jun 20
Scheduled
Alnylam Pharmaceuticals, Inc.
0
$96.03
-$168,085.34
—
14.5K
+1
Mar 20
Scheduled

It looks like there's no data for these filter options. Maybe you'll be interested in these options instead.

Loading...

Want to view more results?

Unlock the hidden results with your Benzinga Account now. No purchase required.